Cardiovascular diseases are a major comorbidity in HIV-infected patients, necessitating aggressive risk factor reduction to decrease mortality.
The lifespan of HIV-infected patients is increasing, and cardiovascular diseases becoming a major comorbidity and leading cause of death in this population due to high prevalence of the cardiac risk factors and possibly due to the use of antiretroviral therapy. Aggressive reduction of these risk factors and treatment of cardiovascular diseases are crucial to decrease the cardiovascular mortality in these patients.
Rami Alharethi (2013) studied this question.